Showing 161 - 180 results of 542 for search '(( 10 (((teer OR per) decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 19 1 decrease ))*', query time: 0.16s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168

    Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region by Dagenais, Renée

    Published 2017
    “…Results Five studies met the inclusion criteria. CYP2C9, CYP2C19, and multidrug resistance protein 1 C3435T variants were evaluated. …”
    Get full text
    Get full text
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174

    Age-Related Differences of the Athlete`s Heart by Kneffel, Zsuzsanna

    Published 2013
    “…In the competitive age (19-35 years) athletes have a higher E/A than non-athletes (1.98 ± 0.37, vs. 1.73 ± 0.31, p = 0.013). …”
    Get full text
  15. 175

    Synthesizing New Anodes From Qatalum's 1st Cut Spl by Hani Holozadah, Abdullah

    Published 2014
    “…This might result in extending the life time of the carbon anodes and decrease the number of carbon dioxide kilograms that are released per a ton of produced Al metal. …”
    Get full text
    Get full text
  16. 176

    Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey by Turner, Stuart J.

    Published 2013
    “…Univariate sensitivity analysis highlighted that increasing the duration of voriconazole by >1.2 days or decreasing LAmB by >1.0 days changes the result. Monte Carlo Simulation resulted in 69.4% of simulations favouring voriconazole per patient treated.Conclusion: There is a strong likelihood that voriconazole is economically more favourable than LAmB in the empiric treatment of IFI in Turkey.…”
    Get full text
    Get full text
  17. 177
  18. 178

    Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial by El Hajj, Maguy

    Published 2015
    “…Secondary outcomes constitute quality-of-life adjustment as well as cost analysis of program resources consumed, including per case and patient outcome. Discussion: If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease the smoking burden. …”
    Get full text
    Get full text
  19. 179
  20. 180